Shengtai Pharmaceutical's ROA from the third quarter of 2013 to the third quarter of 2012 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Shengtai Pharmaceutical's ROA in the third quarter of 2013?
Shengtai Pharmaceutical, Inc. achieved a return on average assets (ROA) of 0.32 % in its third quarter of 2013, this is above SGTI's average return on assets of 0%.
Shengtai Pharmaceutical, Inc. assets over the 12 months ending in its third quarter of 2013 are valued at $176 million

ROA decreased relative to the period ending Dec 31 2012, due to the decline in net income.

However, within the Healthcare sector Shengtai Pharmaceutical, Inc. achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the second quarter of 2013 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2013) III. Quarter	(Dec 31 2012) II. Quarter	(Sep 30 2012) I. Quarter	(Jun 30 2012) IV. Quarter	(Mar 31 2012) III. Quarter
Y / Y Total Assets Change	139.73 %	25.12 %	16.38 %	-2.04 %	-
Y / Y Net Income Change	7.04 %	-	-77.78 %	-	-95.74 %
Net Income (TTM) in million	1	1	0	1	4
Return On Assets (TTM)	0.32 %	0.37 %	0.16 %	0.68 %	3.24 %
SGTI's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	184	177	169	173	77
Seq. Total Assets Change	3.76 %	4.77 %	-1.94 %	124.88 %	-45.85 %
Seq. Net Income Change	-59.72 %	33.07 %	-	-	-

SGTI's 5 Years Annual ROA >> Back to SGTI Management Effectiveness >> Compare SGTI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Shengtai Pharmaceutical's Assets	$ 184 million	SGTI's Balance sheet
Shengtai Pharmaceutical's Income	$ 0 million	Quarterly SGTI's Income Statement
SGTI's Income by Division		See SGTI's Income by Division

Annual Return On Assets	(Jun 30 2012) FY 2012	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	173	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	1	0	0	0	0
Annual Return On Assets	0.62 %	-	-	-	-

SGTI's 5 Years Annual ROA >> Back to SGTI Management Effectiveness >> Compare SGTI ROA to its Competitors

Comment on SGTI's ROA in the fiscal year ending 2012

In the fiscal year 2012 ROA improved to 0.62 % compared to prior year, due to annual net income growth of % to $1.07 million, while value of Shengtai Pharmaceutical's overall assets grew just by % to $172.59 million, compared to $172.59 a year before.

More Return On Assets Ratios
SGTI's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SGTI's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SGTI's Competitors
Subscribers only: Roa for Shengtai Pharmaceutical's Suppliers
Subscribers only: Return On Assets for SGTI's Customers

You may also want to know
SGTI's Roi	SGTI's Inventory Turnover Ratio	SGTI's Growth Rates	SGTI's Dividend Comparisons
	SGTI's Profitability Ratios	SGTI's Asset Turnover Ratio	SGTI's Dividend Growth
SGTI's Roe	SGTI's Valuation Ratios	SGTI's Financial Strength Ratios	SGTI's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2013, within Healthcare Sector	ROA
Bausch Health Companies Inc	0.60 %
Heska Corporation	0.33 %
Viskase Holdings inc	0.26 %
Nuvasive Inc	0.22 %
Masimo Corp	0.16 %
Tenet Healthcare Corp	0.16 %
Apyx Medical Corp	0.07 %

Date modified: 2026-09-08T15:21:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.